GlobeNewswire

Genomatica brings its naturally sourced Brontide(TM) butylene glycol to Europe

Del

Azelis chosen to distribute; already confirming better personal care formulations

SAN DIEGO and ANTWERP, Belgium, March 20, 2018 (GLOBE NEWSWIRE) -- Genomatica, a widely-recognized technology leader for naturally sourced chemicals, and Azelis, a leading distributor of specialty chemicals, announced that Azelis is now the exclusive distributor for personal care applications of Genomatica's naturally sourced, award-winning Brontide(TM) butylene glycol in Europe. Azelis is already seeing widespread interest in Brontide from major brands and plans to support scores of major customers during Brontide's market introduction. See Brontide introduction video.

Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/689e9f6d-b2ba-4977-ac51-3a74b9e6fba9

http://www.globenewswire.com/NewsRoom/AttachmentNg/7baf9c6b-8b96-4326-8049-a57d4c22a177

A naturally sourced, sustainable cosmetics ingredient; Brontide honored for innovation

Butylene glycol, a colorless organic alcohol, is commonly used in a wide range of personal care products to increase moisture retention (as a humectant), improve texture, and provide antimicrobial properties. Additionally, it is used to evenly disperse plant extracts, flavors and fragrances.

Genomatica produces Brontide biobased butylene glycol from natural, plant-based sugars using its safe and sustainable fermentation-based process technology. This innovative approach has high appeal in personal care applications where demand for natural ingredients is growing. Brontide has already been recognized by the mainstream chemical industry with the prestigious ICIS Innovation Award.

Azelis actively developing formulations; sees strong customer interest

Azelis, a leading global specialty chemicals distributor with over 40,000 customers in 40 countries will provide sales, technical and logistics support for personal care product makers in Europe that are looking for a natural alternative to petroleum-based butylene glycol.

Azelis has also been actively developing and testing multiple personal care product formulations using Genomatica's Brontide, including hydra gels, body sprays, and sunscreens. These have tested well for key formulation attributes such as scent, viscosity, pH and stability.

Azelis reports that demand for natural ingredients has multiplied across its customer base. "We're already seeing strong interest in Genomatica's Brontide butylene glycol," said Tony Craske, Market Segment Director EMEA for Personal Care, Azelis. "Brontide is a perfect example of the new and exciting technologies that we deliver to our personal care partners. This naturally sourced, sustainable high-quality ingredient makes it easy for formulators and brands to improve their products."

"Azelis knows how to highlight the value of a great ingredient and help their customers benefit from it," said Damien Perriman, Genomatica's Senior Vice President, Specialty Chemicals. "Together, we can help make lots of everyday products better for people and the planet."

Genomatica has been producing and shipping tons of Brontide to customers since mid-2017. For samples, companies developing personal care products in Europe should contact Azelis at Brontide.BG@azelis.com; all others should contact Genomatica at Brontide@genomatica.com.

About Azelis

Azelis is a leading distributor of speciality chemicals and food ingredients present in over 40 countries across the globe with around 1,800 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to over 40,000 customers, creating a turnover of €1.8 billion. In the US we operate under a number of renowned co-brands that cater to the various markets in the region.

Throughout our extensive network of 39 application laboratories, our award-winning technical staff help customers develop formulations. We combine a global reach with a local focus to offer a reliable, integrated service to local customers and attractive business opportunities to principals. And we believe in building and nurturing solid, honest and transparent relationships with our people and partners.

Creating value, growing together. www.azelis.com

About Genomatica

Genomatica is a widely-recognized leader in bioengineering. It develops biobased process technologies that enable a better way to produce widely-used chemicals, from alternative feedstocks, with better economics, sustainability and performance. Genomatica has earned widespread acclaim for its technology and commercialization achievements. Awards include the Kirkpatrick Award, for "the most noteworthy chemical engineering technology commercialized in the world" and the ICIS Innovation Award for its Brontide(TM) butylene glycol. To learn more, visit www.genomatica.com

For more information

For Azelis: Marina Kaptein, +32 3 613 0125, marina.kaptein@azelis.com
For Genomatica: Patti Bianchi, CG Life, +1.630.841.1771, pbianchi@cglife.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Genomatica via Globenewswire

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Eurotunnel entrusts the mid-life renovation of its Passenger Shuttles to Bombardier Transportation20.3.2019 08:30:00 CETPressemelding

BERLIN, March 20, 2019 (GLOBE NEWSWIRE) -- As part of the 2018-2026 mid-life programme, Eurotunnel is signing a contract with Bombardier Transportation to renovate nine “PAX” Shuttles. Composed in total of 254 wagons, each 800-meter long shuttle is made up for passengers’ vehicles with passengers remaining in their vehicles during for the 35-minute Channel crossing. In the 25-year period since the opening of the Channel Tunnel, these Shuttles have each travelled an average of 300 round trips per month and have enabled over 236 million passengers to travel very comfortably between France and Great-Britain. The contract is valued at €150 million ($171 million) over a period of 7 years. Deliveries of the newly refurbished Shuttles will start in mid-2022 and continue until mid-2026. Teams from Bombardier France and Belgium1 originally designed and built these unique vehicles in the 90’s and launched Bombardier’s activities in France. This year, the company celebrates 30 years since its est

Standard Lithium Engages WorleyParsons’ Advisian for Preliminary Economic Assessment of Its Southern Arkansas Project20.3.2019 08:01:00 CETPressemelding

VANCOUVER, British Columbia, March 20, 2019 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L), is pleased to announce that it has engaged Advisian, the consulting arm of WorleyParsons Canada Services Ltd (WorleyParsons) to complete a Preliminary Economic Assessment (PEA) of its flagship 150,000 acre project in the south-central region of Arkansas, USA. Advisian is part of WorleyParsons, one of the world’s largest engineering and project delivery firms, servicing the global resource, energy, and infrastructure markets with 26,910 personnel across 115 offices in 42 countries around the globe. Advisian and WorleyParsons have carried out many lithium studies for brine and produced-water projects in North and South America for a range of operating and development-stage clients. WorleyParsons also has extensive experience in planning, developing and building chemical plants in the US Gulf Coast region. Standard Lithium has e

ISSI HyperFlash™ memory has successfully been designed into the NXP i.MX RT106A MCU-based solution for AVS (Alexa Voice Service)19.3.2019 21:30:00 CETPressemelding

MILPITAS, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Integrated Silicon Solution, Inc. a leader in advanced memory solutions, today announced the adoption of HyperFlash™ memory IS26KL256S-DABLI00 (256Mb 3.3V BGA package) with NXP’s i.MX RT106A MCU based solution for AVS (Alexa Voice Service). The Alexa Voice Service (AVS) is a virtual assistant developed by Amazon that provides cloud-based automatic speech recognition (ASR) and natural language understanding (NLU) to provide information, media playback, communication and smart device control capabilities to consumers. HyperFlash™ memory based on the HyperBus™ technology dramatically improves memory performance while reducing pin count and board space, essential for NXP’s implementation to save BOM cost without compromising performance to do XIP (execute-in-place) operations. “NXP is an important partner for us. We are very glad that NXP adopted our HyperFlash™ solution. HyperFlash™ fits nicely in the application to meet the increasingl

NLS Pharmaceutics Announces the Completion of the Merger between NLS Pharma Ltd., NLS-1 Pharma Ltd. and NLS-0 Pharma, Unifying the Global Operations and Development of Nolazol®19.3.2019 21:05:00 CETPressemelding

The combined company was named NLS Pharmaceutics Ltd (NLS) STANS, Switzerland, March 19, 2019 (GLOBE NEWSWIRE) -- NLS Pharmaceutics Ltd (NLS), a Swiss biotech firm focusing on the development of novel treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) and other cognitive disorders and impairments, today announced the closing of the merger of NLS Pharma Ltd., NLS-1 Pharma Ltd. and NLS-0 Pharma, effective immediately. The combined company was named “NLS Pharmaceutics Ltd.” The sideways merger brings together the global operations and assets of the three companies in order to streamline the development of Nolazol®, a controlled release formulation of mazindol that is currently being developed as a non-amphetamine DEA schedule C-4 treatment option for ADHD and narcolepsy, as well as a promising pipeline of early to late-stage compounds focusing on ADHD, sleep disorder and other rare diseases. Leading the combined company as Chief Executive Officer is Alex Zwyer, who served as c

INVNT Recognised for Xero and TEDxSydney Work at The Event Marketing Awards 201919.3.2019 14:30:00 CETPressemelding

HONG KONG, March 19, 2019 (GLOBE NEWSWIRE) -- INVNT, the global live brand storytelling agency™, in partnership with Xero has received the Best Corporate Event Gold Award at the prestigious Event Marketing Awards 2019 organised by Campaign Asia-Pacific and CEI, for its production, management and design of Xerocon Brisbane 2018 – Australasia’s largest technology conference for the accounting industry. During the ceremony, which was held at the Eaton Club in Hong Kong on Tuesday evening local time, INVNT was also recognised with the Best Sustainability Bronze Award alongside client TEDxSydney, for the production of the not-for-profit organisation’s flagship event in 2018, which was themed around the concept of HumanKind and saw the agency devise and implement a series of environmentally friendly initiatives. Now in their fourth year, the Event Marketing Awards organised by Campaign Asia-Pacific and CEI recognise best practice in the creation, planning, production and management of innova

Crocus Technology Unveils its 2nd Generation TMR Linear Sensor with Unparalleled Temperature Stability19.3.2019 13:00:00 CETPressemelding

The CT100 is a unique TMR magnetic sensor with industry-leading performance SANTA CLARA, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Crocus Technology Inc., a leading supplier of disruptive Tunnel Magneto-Resistance (TMR) sensors, today announces the CT100 device, an advanced, high-performance linear (1D) magnetic sensor based on Crocus’ patented and unique TMR-based technology. The CT100 has best-in-class performance across a wide temperature range coupled with an extremely low linearity error, low hysteresis, and low noise which enables it to address many consumer, industrial and automotive applications and markets. The CT100 outperforms competitors’ xMR or Hall-based linear magnetic sensor technology available today in terms of performance, deviation over temperature, current consumption, and overall robustness. The CT100 does not require any expensive flux guides or concentrators, chopping circuits or set/reset pulses and operates over a wide magnetic field range. Crocus’s revolutio